VENEE TUBMAN to Humans
This is a "connection" page, showing publications VENEE TUBMAN has written about Humans.
Connection Strength
0.473
-
Newborn screening results for sickle cell disease from the ASH Consortium on Newborn Screening in Africa (CONSA). Blood Adv. 2026 05 12; 10(9):3200-3206.
Score: 0.026
-
Concomitant sickle cell disease and systemic lupus erythematosus: A single-center case series. Pediatr Blood Cancer. 2024 10; 71(10):e31194.
Score: 0.023
-
Unswitched memory B cell deficiency in children with sickle cell disease and response to pneumococcal polysaccharide vaccine. Am J Hematol. 2024 06; 99(6):1084-1094.
Score: 0.022
-
Expert consensus on the management of infusion-related reactions (IRRs) in patients with sickle cell disease (SCD) receiving crizanlizumab: a RAND/UCLA modified Delphi panel. Ann Hematol. 2024 Jun; 103(6):1909-1917.
Score: 0.022
-
Unraveling the mystery of the spleen. Am J Hematol. 2024 02; 99(2):150-151.
Score: 0.022
-
Ketamine for Pain in Sickle Cell Disease Reduces Opioid Usage. J Pain Symptom Manage. 2024 03; 67(3):e169-e175.
Score: 0.022
-
New ASH initiatives to improve patient care in the long-overlooked sickle cell disease. Blood. 2023 07 20; 142(3):230-234.
Score: 0.021
-
Multi-center retrospective study of children with sickle cell disease admitted to pediatric intensive care units in the United States. Sci Rep. 2023 04 25; 13(1):6758.
Score: 0.021
-
Global perspectives on cellular therapy for children with sickle cell disease. Curr Opin Hematol. 2022 11 01; 29(6):275-280.
Score: 0.020
-
Regional anesthesia for sickle cell disease vaso-occlusive crisis: A single-center case series. Pediatr Blood Cancer. 2022 06; 69(6):e29695.
Score: 0.019
-
Indications for transfusion in the management of sickle cell disease. Hematology Am Soc Hematol Educ Program. 2021 12 10; 2021(1):696-703.
Score: 0.019
-
Allele-Specific Recombinase Polymerase Amplification to Detect Sickle Cell Disease in Low-Resource Settings. Anal Chem. 2021 03 23; 93(11):4832-4840.
Score: 0.018
-
Fever Management in Sickle Cell Disease in Low- and Middle-Income Countries: A Survey of SCD Management Programs. Am J Trop Med Hyg. 2020 04; 102(4):902-904.
Score: 0.017
-
Mother knows best: The caregiver's perspective on clinical trials for sickle cell disease highlights the challenges of providing care in Africa. Pediatr Blood Cancer. 2020 02; 67(2):e28054.
Score: 0.016
-
Clinical and laboratory outcomes following total or partial splenectomy in patients with hereditary spherocytosis. Pediatr Hematol Oncol. 2019 Sep; 36(6):382-389.
Score: 0.016
-
Turf wars: exploring splenomegaly in sickle cell disease in malaria-endemic regions. Br J Haematol. 2017 06; 177(6):938-946.
Score: 0.014
-
Acute lymphoblastic leukemia in a patient with MonoMAC syndrome/GATA2 haploinsufficiency. Pediatr Blood Cancer. 2016 10; 63(10):1844-7.
Score: 0.013
-
Newborn Screening for Sickle Cell Disease in Liberia: A Pilot Study. Pediatr Blood Cancer. 2016 Apr; 63(4):671-6.
Score: 0.013
-
The Clinically Tested Gardos Channel Inhibitor Senicapoc Exhibits Antimalarial Activity. Antimicrob Agents Chemother. 2016 01; 60(1):613-6.
Score: 0.012
-
A Prospective Cohort Quality Improvement Study to Reduce the Time to Antibiotics for New Fever in Neutropenic Pediatric Oncology Inpatients. Pediatr Blood Cancer. 2016 Jan; 63(1):112-7.
Score: 0.012
-
Guidelines for the Standard Monitoring of Patients With Thalassemia: Report of the Thalassemia Longitudinal Cohort. J Pediatr Hematol Oncol. 2015 Apr; 37(3):e162-9.
Score: 0.012
-
Sickle solubility test to screen for sickle cell trait: what's the harm? Hematology Am Soc Hematol Educ Program. 2015; 2015:433-5.
Score: 0.012
-
Building partnerships to target sickle cell anemia in Africa. Am J Hematol. 2013 Dec; 88(12):983.
Score: 0.011
-
Sickle cell disease caused by Hb S/Qu?bec-CHORI: treatment with hydroxyurea and response. Pediatr Blood Cancer. 2007 Aug; 49(2):207-10.
Score: 0.007
-
Acquired immune cytopenias post-cardiac transplantation respond to rituximab. Pediatr Blood Cancer. 2007 Mar; 48(3):339-44.
Score: 0.007
-
X-linked gray platelet syndrome due to a GATA1 Arg216Gln mutation. Blood. 2007 Apr 15; 109(8):3297-9.
Score: 0.007
-
Recombinase polymerase amplification for single nucleotide polymorphism-specific detection of ?C variant in sickle cell disease. Anal Biochem. 2025 Oct; 705:115919.
Score: 0.006
-
Engaging Parents of Children With Sickle Cell Disease in Shared Decision-Making for Hydroxyurea: The ENGAGE-HU Study. Pediatr Blood Cancer. 2025 May; 72(5):e31639.
Score: 0.006
-
Comprehensive normalization and binary classification methods for enhanced sensitivity and reproducibility in Luminex assay quantitation. J Immunol Methods. 2025 03; 538:113826.
Score: 0.006
-
A multiplexed, allele-specific recombinase polymerase amplification assay with lateral flow readout for sickle cell disease detection. Lab Chip. 2024 08 20; 24(17):4115-4127.
Score: 0.006
-
Progressive Thrombocytopenia, Splenomegaly, and Abnormal Tone in an Infant With Growth Faltering. Pediatrics. 2024 07 01; 154(1).
Score: 0.006
-
Unique Hemoglobinopathy Pattern Following Treatment with Voxelotor. Ann Clin Lab Sci. 2023 Jul; 53(4):647-652.
Score: 0.005
-
The Consortium on Newborn Screening in Africa for sickle cell disease: study rationale and methodology. Blood Adv. 2022 12 27; 6(24):6187-6197.
Score: 0.005
-
Enablers and barriers to newborn screening for sickle cell disease in Africa: results from a qualitative study involving programmes in six countries. BMJ Open. 2022 03 09; 12(3):e057623.
Score: 0.005
-
A Phase 3 Randomized Trial of Voxelotor in Sickle Cell Disease. N Engl J Med. 2019 08 08; 381(6):509-519.
Score: 0.004